Overview
Liu Teng practices practicing medicine in Zhengzhou, China.
Their clinical expertise encompasses Retinoblastoma, Parathyroid Cancer, and Parathyroid Adenoma.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Liu Teng
Is Liu Teng a top-rated expert for Retinoblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Liu Teng is classified as an Experienced expert for Retinoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Liu Teng participate in research or clinical trials?
Yes. Liu Teng has published 18 articles and abstracts on conditions like Retinoblastoma. You can view a list of Liu Teng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Parathyroid AdenomaTeng isExperienced. Learn about Parathyroid Adenoma.
- Parathyroid CancerTeng isExperienced. Learn about Parathyroid Cancer.
- RetinoblastomaTeng isExperienced. Learn about Retinoblastoma.